La Crema De Rebeca's skin-lightening cream is an unapproved, misbranded drug containing high mercury, FDA warns.
What happened
FDA reviewed the firm's website in April 2026 and obtained a sample of “La Crema de Rebeca.” Laboratory analysis confirmed the cream contains high levels of mercury. FDA also found website claims that the product treats acne, dark spots, freckles, rosacea, and moles, while the labeling does not declare mercury.
What FDA found
The cream is an unapproved new drug because FDA has no approved application for it and it is not generally recognized as safe and effective for its labeled uses.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)Website claims that the cream removes acne, dark spots, freckles, rosacea, and moles make it a drug intended to treat disease or affect the body.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)The labeling is false or misleading because it does not disclose that the product contains mercury.
FD&C Act section 502(a), 21 U.S.C. 352(a)Laboratory testing found high levels of mercury, which can be absorbed through the skin and cause kidney and neurological damage.
Selling or shipping the misbranded cream in interstate commerce is prohibited.
FD&C Act section 301(a), 21 U.S.C. 331(a)
What FDA wants
FDA tells the company to send a written response within 15 business days to FDAAdvisory@fda.hhs.gov. The response must include steps taken to correct the violations, steps to prevent recurrence, related documentation, and reference number 728782.
Who should pay attention
- consumers using skin-lightening creams
- retailers and online marketplaces selling small-brand creams
- clinicians advising pregnant people and children on skin products
This is a summary. Read the original letter on fda.gov.